[go: up one dir, main page]

WO2003040335A3 - Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries - Google Patents

Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries Download PDF

Info

Publication number
WO2003040335A3
WO2003040335A3 PCT/US2002/035618 US0235618W WO03040335A3 WO 2003040335 A3 WO2003040335 A3 WO 2003040335A3 US 0235618 W US0235618 W US 0235618W WO 03040335 A3 WO03040335 A3 WO 03040335A3
Authority
WO
WIPO (PCT)
Prior art keywords
leader peptides
export
proteins
folded
cytoplasm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2002/035618
Other languages
English (en)
Other versions
WO2003040335A2 (fr
Inventor
George Georgiou
Matthew Delisa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Development Foundation
Original Assignee
Research Development Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Foundation filed Critical Research Development Foundation
Priority to CA002465724A priority Critical patent/CA2465724A1/fr
Priority to JP2003542582A priority patent/JP2005522188A/ja
Priority to AU2002360348A priority patent/AU2002360348B8/en
Priority to EP02795597A priority patent/EP1451367A4/fr
Publication of WO2003040335A2 publication Critical patent/WO2003040335A2/fr
Publication of WO2003040335A3 publication Critical patent/WO2003040335A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43595Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1051Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62DNA sequences coding for fusion proteins
    • C12N15/625DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/034Fusion polypeptide containing a localisation/targetting motif containing a motif for targeting to the periplasmic space of Gram negative bacteria as a soluble protein, i.e. signal sequence should be cleaved
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/60Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/61Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/95Fusion polypeptide containing a motif/fusion for degradation (ubiquitin fusions, PEST sequence)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne des procédés d'isolement de peptides leader pouvant diriger l'exportation de protéines hétérologues à partir du cytoplasme bactérien. Lesdits procédés se fondent sur le criblage de bibliothèques de peptides leader putatifs ou de mutants de peptides leader pour des séquences qui permettent une exportation rapide et peuvent ainsi empêcher la dégradation d'une protéine reporter à durée de vie courte dans le cytoplasme. Lesdits peptides leader mutants identifiés dans la présente invention peuvent conférer de manière significative des niveaux d'états stables d'exportation plus élevés non seulement pour une protéine reporter à durée de vie courte mais aussi pour d'autres protéines stables à durée de vie longue. Lesdits peptides leader peuvent être utilisés pour diriger ou augmenter la sécrétion des protéines. L'invention concerne de plus des procédés d'exportation de protéines pliées de manière cytoplasmique par l'intermédiaire d'une voie Tat. Des protéines présentant des liaisons disulfure sont pliées en premier à l'intérieur du cytoplasme dans des souches mutantes appropriées oxydantes. Lesdites protéines pré-pliées de manière cytoplasmique qui contiennent des liaisons disulfure sont alors exportées par l'intermédiaire de la voie Tat.
PCT/US2002/035618 2001-11-05 2002-11-05 Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries Ceased WO2003040335A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002465724A CA2465724A1 (fr) 2001-11-05 2002-11-05 Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries
JP2003542582A JP2005522188A (ja) 2001-11-05 2002-11-05 バクテリア内での遺伝子組み換え体蛋白質の分泌を促進するためのリーダー・ペプチド及びその単離方法
AU2002360348A AU2002360348B8 (en) 2001-11-05 2002-11-05 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
EP02795597A EP1451367A4 (fr) 2001-11-05 2002-11-05 Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33745201P 2001-11-05 2001-11-05
US60/337,452 2001-11-05
US60/ 2002-09-13

Publications (2)

Publication Number Publication Date
WO2003040335A2 WO2003040335A2 (fr) 2003-05-15
WO2003040335A3 true WO2003040335A3 (fr) 2003-12-31

Family

ID=23320598

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/035618 Ceased WO2003040335A2 (fr) 2001-11-05 2002-11-05 Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries

Country Status (3)

Country Link
EP (1) EP1451367A4 (fr)
CN (1) CN100564540C (fr)
WO (1) WO2003040335A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130045871A1 (en) * 2010-03-18 2013-02-21 Cornell University Engineering correctly folded antibodies using inner membrane display of twin-arginine translocation intermediates
CN103797122A (zh) * 2011-04-08 2014-05-14 安瑟生物科技私人有限公司 用于大肠杆菌中异源蛋白质生产的新的表达和分泌载体系统
KR101470595B1 (ko) 2012-08-01 2014-12-10 대구가톨릭대학교산학협력단 세포외로 분비되는 녹색형광단백질, 이를 코딩하는 유전자 및 이 유전자 발현을 위한 벡터
CN102851270A (zh) * 2012-08-03 2013-01-02 江南大学 一种杂交链霉菌胰蛋白酶酶原及其应用
GB201713732D0 (en) * 2017-08-25 2017-10-11 Alta Innovations Ltd Tat expression system
CN109575116B (zh) * 2018-11-09 2022-04-22 广东海洋大学 一种线粒体定位导肽及其发现方法与应用
CN110616227A (zh) * 2019-09-30 2019-12-27 天津科技大学 一种来源于黄粉虫的抗冻蛋白的基因、重组表达载体、工程菌株和应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110860A1 (en) * 2000-09-18 2002-08-15 Sierd Bron Twin-arginine translocation in Bacillus
US20020182672A1 (en) * 2000-10-10 2002-12-05 Marc Kolkman Enhanced secretion of a polypeptide by a microorganism

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045136A1 (fr) * 1998-03-05 1999-09-10 University Of British Columbia Procedes d'analyse d'inhibiteurs de secretion de type iii
EP1068339B1 (fr) * 1998-04-01 2008-07-23 The Governors of the University of Alberta Compositions et methodes de secretion proteique

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020110860A1 (en) * 2000-09-18 2002-08-15 Sierd Bron Twin-arginine translocation in Bacillus
US20020182672A1 (en) * 2000-10-10 2002-12-05 Marc Kolkman Enhanced secretion of a polypeptide by a microorganism

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DELISA M.P. ET AL.: "Folding quality control in the export of proteins by the bacterial twin-arginine translocation pathway", PROC. NATL. ACAD. SCI. USA, vol. 100, no. 10, 13 May 2003 (2003-05-13), pages 6115 - 6120, XP002970386 *
DELISA M.P.: "Genetic analysis of the twin arginine translocator secretion pathway in bacteria", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 277, no. 33, 16 August 2002 (2002-08-16), pages 29825 - 29831, XP002970385 *
See also references of EP1451367A4 *

Also Published As

Publication number Publication date
CN1788092A (zh) 2006-06-14
EP1451367A4 (fr) 2006-06-14
CN100564540C (zh) 2009-12-02
EP1451367A2 (fr) 2004-09-01
WO2003040335A2 (fr) 2003-05-15

Similar Documents

Publication Publication Date Title
WO2000020555A3 (fr) Systeme de transformation dans le domaine des hotes fongiques filamenteux
WO1997033996A3 (fr) Bikunine humaine
CA2265976A1 (fr) Expression puissante de proteines
AU4162400A (en) Derivatives of the b or z domain from staphylococcal protein a (spa) interactingwith at least one domain of human factor viii
WO2002072605A3 (fr) Technique d'expression pour des proteines contenant un fragment d'anticorps isotype chimerique
EP1013760A3 (fr) Produits stables de la protéine bactéricide augmentant la perméabilité et compositions thérapeutiques les contenant
WO2000005367A3 (fr) Proteines humaines a domaines hydrophobes et adn codant pour ces proteines
EP1092774A3 (fr) Antigène de Borrelia burgdorferi OspA, gène le codant et leur utilisations
AU6020598A (en) Dna sequences, vectors, and fusion polypeptides for secretion of polypeptides infilamentous fungi
WO2005071088A3 (fr) Molecules d'acides nucleiques recombinantes, cassettes d'expression, et bacteries, et leurs methodes d'utilisation
WO2003060143A3 (fr) Systeme d'expression de proteine efficace
CA2365697A1 (fr) Procedes perfectionnes pour la production de peptides recombinants
WO2003031598A3 (fr) Sequences d'acides nucleiques et d'acides amines codant des polypeptides de facteur viii a expresseur a haut rendement et leurs procedes d'utilisation
WO2003040335A3 (fr) Genie de peptides leader pour la secretion de proteines recombinees dans des bacteries
AU2001275267A1 (en) Leader peptides for enhancing secretion of recombinant protein from a host cell
CA2204151A1 (fr) Adn complementaire codant pour un recepteur de type ii de proteines morphogenetiques osseuses (bmp)
WO2003004636A3 (fr) Vecteurs d'expression
FR2692282B1 (fr) Clonage du gene codant pour la proteine gp28.5 de t. gondii; fragments peptidiques issus de ladite proteine et leurs applications.
WO1999022005A3 (fr) D-glucosaminyle 3-o-sulfotransferases de sulfate d'heparane et utilisations associees
WO2000058465A3 (fr) Analogues polypeptidiques de flint
WO2002002771A3 (fr) Nouveau gene hsparc-11 et procedes de fabrication et d'utilisation de ce dernier
CA2194032A1 (fr) Sequence d'adn fusionnee, proteine fusionnee exprimee par ladite sequence d'adn et methode d'expression de ladite proteine fusionnee
WO2004089973A3 (fr) Peptides, polypeptides et proteines d'immunogenicite reduite et leurs procedes de production
WO2000028033A3 (fr) Nouveaux adn et polypeptides
WO2002031127A3 (fr) Clonage et expression recombinante de phopholipase a2 du groupe xii, secretee, de mammifere

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2465724

Country of ref document: CA

Ref document number: 2002360348

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003542582

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2002795597

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 20028267346

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 2002795597

Country of ref document: EP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)